Guangzhou General Hospital of Guangzhou Military Command

How to interpret these research links

Connected source records

The exact organization name Guangzhou General Hospital of Guangzhou Military Command appears in 12 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials12

Recruiting shown0

Roles2

SourceClinicalTrials.gov

Clinical trials

12 shown

Pharmacokinetics and Pharmacodynamics of Sugammadex Dosed by Corrected Body Weight for Reversal of Vecuronium in Obese PatientsNCT05328778 · lead sponsor · 2022-04-14

COMPLETED

Pharmacokinetics and Pharmacodynamics of Sugammadex in Reversal of Vecuronium-induced Neuromuscular BlockadeNCT04131218 · lead sponsor · 2019-07-16

UNKNOWN

Effect of Laparoscopic Roux-en-Y Gastric Bypass Surgery on Non-severe Obesity With Type 2 Diabetes MellitusNCT02091323 · lead sponsor · 2014-03-01

UNKNOWN

Effects of Different Types of Anesthesia on Stress Response in Laparoscopic Gastric Bypass for Type 2 Diabetes MellitusNCT01963546 · lead sponsor · 2014-03-01

UNKNOWN

Pharmacokinetics of Dexmedetomidine in Morbid ObesityNCT01864187 · lead sponsor · 2013-06-01

UNKNOWN

Mesenchymal Stem Cells Transplantation to Patients With Parkinson's DiseaseNCT01446614 · lead sponsor · 2011-10-01

UNKNOWN

Asymmetric DBS for PD : A Multicenter, Prospective, Single Arm, Open Label StudyNCT04616521 · collaborator · 2021-01-01

NOT_YET_RECRUITING

Safety and Exploratory Efficacy Study of UCMSCs in Patients With Alzheimer's DiseaseNCT02672306 · collaborator · 2017-10-20

UNKNOWN

REduction of rIsk for Contrast Induced NephropathyNCT01402232 · collaborator · 2013-01-01

UNKNOWN

Compare the Outcomes of XT and XEC Adjuvant Chemotherapy in HER2-negative Luminal B Breast Cancer PatientsNCT01779531 · collaborator · 2013-01-01

UNKNOWN

Erlotinib Versus Gemcitabine/Cisplatin as (Neo)Adjuvant Treatment in Non-small Cell Lung CancerNCT01407822 · collaborator · 2011-12-05

UNKNOWN

Curative Effect Study of Endostatin Combined With Chemoradiotherapy to Non-small-cell Lung CancerNCT01218594 · collaborator · 2009-05-01

UNKNOWN

Drugs studied in this sponsor's trials

3 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Guangzhou General Hospital of Guangzhou Military Command as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

dexmedetomidine2

sugammadex2

erlotinib1

dexmedetomidine RxCUI 48937 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials sugammadex RxCUI 1726988 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials erlotinib RxCUI 337525 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

collaborator6

lead sponsor6

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.